Saudi Arabia Wealth Fund Reveals Investments in Founders Fund, Tiger Global (Bloomberg)
Saudi Arabia’s portfolio of venture investments includes Tiger Global Management and Peter Thiel’s Founders Fund, recent updates to its website show. The firms are among the roughly 50 venture capital and growth funds that Saudi Arabia’s Sanabil Investments, the venture arm of its $620 billion Public Investment Fund, has begun publishing online. It’s rare for limited partners — the investors in VC funds — to make their positions public.
Bull Asset and Silver Leaf Cash in on China Property Bond Trades (Hedge Week)
China-based hedge funds Shanghai Bull Asset Management (Bull Asset) and Shanghai Silver Leaf Investment Co (Silver Leaf) have both booked big returns by exiting a lucrative trade son the country’s property bonds, according to a report by Bloomberg. Both firms have decided to unwind their wagers on concerns over the sector’s debt burden. Bull Asset has reportedly sold all its CIFI Holdings Group Co bonds after cut-price purchases of the troubled assets helped spur a 523% increase in its distressed-debt strategy in 2022.
Sotheby’s to Host Auction of NFTs from Failed Hedge Fund 3AC Collection (CoinSpeaker)
The total value of NFTs held by Three Arrows Capital (3AC) is $2.4 million. The Grails NFT collection includes NFTs from some popular Web3 projects as well as from some of the most notable artists. On Wednesday, April 19, the popular London-based auction house Sotheby’s announced that it will facilitate the sale of the “Grails” NFT collection, originally owned by the now-defunct hedge fund Three Arrows Capital (3AC) as well as its NFT-collecting fund Starry Night Capital.
Thursday 4/20 Insider Buying Report: REVB, NTIC (Nasdaq.com)
On Tuesday, Revelation Biosciences’ Director, George F. Tidmarsh, made a $59,740 purchase of REVB, buying 51,500 shares at a cost of $1.16 a piece. Investors have the opportunity to grab REVB even cheaper than Tidmarsh did, with shares trading as low as $1.09 at last check today which is 5.9% below Tidmarsh’s purchase price. Revelation Biosciences is trading up about 2.8% on the day Thursday. And also on Tuesday, Director Sarah E. Kemp purchased $30,000 worth of Northern Technologies International, purchasing 2,473 shares at a cost of $12.13 each. This buy marks the first one filed by Kemp in the past year. Northern Technologies International is trading off about 1.5% on the day Thursday.
Over $25M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying (Benzinga)
Ambrx Biopharma: The Trade: Ambrx Biopharma Inc. (AMAM) 10% owner Cormorant Private Healthcare Fund III LP acquired a total of 2,597,896 shares an average price of $9.75. To acquire these shares, it cost around $25.32 million. Alta Equipment Group: The Trade: Alta Equipment Group Inc. (ALTG) 10% owner Bryant Riley acquired a total of 84,000 shares at an average price of $13.76. To acquire these shares, it cost around $1.16 million.
